9/18/26 16:10 | 9/16/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | M.d | 122 | 9.88 | 0 | 12 | 45 | 40 | D | | | | | | | | | | | | | | |
9/18/26 16:10 | 9/16/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | S.d | -202 | 16.33 | 0 | -12 | -24 | 40 | D | | | | | | | | | | | | | | |
9/11/26 16:10 | 9/10/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | M.d | 82 | 8.04 | 0 | 10 | 34 | 40 | D | | | | | | | | | | | | | | |
9/11/26 16:10 | 9/10/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | S.d | -179 | 17.62 | 0 | -10 | -20 | 40 | D | | | | | | | | | | | | | | |
8/19/26 16:10 | 8/17/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | M.dm | 710 | 9.88 | 0 | 72 | | 40 | D | | | | | | | | | | | | | | |
8/19/26 16:10 | 8/17/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | S.dm | -1,450 | 19.94 | 0 | -73 | -65 | 40 | D | | | | | | | | | | | | | | |
5/11/26 16:05 | 5/7/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | M.d | 184 | 9.88 | 0 | 19 | | 0 | D | | | | | | | | | | | | | | |
5/11/26 16:05 | 5/7/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | S.d | -449 | 24.12 | 0 | -19 | -98 | 0 | D | | | | | | | | | | | | | | |
5/7/26 16:16 | 5/6/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | M.d | 378 | 8.04 | 0 | 47 | | 0 | D | | | | | | | | | | | | | | |
5/7/26 16:16 | 5/6/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | S.d | -949 | 20.19 | 0 | -47 | -99 | 0 | D | | | | | | | | | | | | | | |
5/1/26 16:37 | 4/29/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | S.m | -223 | 13.16 | 0 | -17 | -98 | 0 | D | | | | | | | | | | | | | | |
4/3/26 15:14 | 4/1/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | S.m | -271 | 16.96 | 0 | -16 | -48 | 17 | D | | | | | | | | | | | | | | |
3/31/26 16:10 | 3/28/26 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | PA | O | CFO | M.d | 0 | 0.00 | 0 | 24 | 266 | 33 | D | | | | | | | | | | | | | | |
4/1/25 16:11 | 3/28/25 | AVTX | Avalo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | MD | O | CFO | M.d | 0 | 0.00 | 0 | 24 | | 17 | D | | | | | | | | | | | | | | |